The U.S. Department of Justice serves as counsel for its citizens. It represents them in enforcing the law in the public interest. Through its thousands of lawyers, investigators, and agents, the Department plays the key role in protection against criminals and subversion, ensuring healthy business competition, safeguarding the consumer, and enforcing drug, immigration, and naturalization laws.
The Department of Justice was established by act of June 22, 1870 (28 U.S.C. 501, 503, 509 note), with the Attorney General as its head. The affairs and activities of the Department of Justice are generally directed by the Attorney General.
- Agency URL:
- Alcohol, Tobacco, Firearms, and Explosives Bureau
- Antitrust Division
- Drug Enforcement Administration
- Executive Office for Immigration Review
- Federal Bureau of Investigation
- Federal Prison Industries
- Foreign Claims Settlement Commission
- Immigration and Naturalization Service
- Justice Programs Office
- Juvenile Justice and Delinquency Prevention Office
- National Institute of Corrections
- National Institute of Justice
- Parole Commission
- Prisons Bureau
- United States Marshals Service
This final rule finalizes two proposed rules in order to update and improve the regulations of the Office of Justice Programs (OJP) implementing the Public Safety Officers' Benefits (PSOB) Program, in order to incorporate several statutory changes enacted in recent years, address some gaps in the regulations, and improve the efficiency of the...
Nondiscrimination on the Basis of Disability; Notice of Withdrawal of Four Previously Announced Rulemaking Actions
The Department of Justice is announcing the withdrawal of four previously announced Advance Notices of Proposed Rulemaking (ANPRMs), pertaining to title II and title III of the Americans with Disabilities Act (ADA), for further review.
The Office of Juvenile Justice and Delinquency Prevention (``OJJDP'') of the Office of Justice Programs (``OJP'') published in the Federal Register on January 17, 2017, a partial Final Rule amending the formula grant program (``Formula Grant Program'') regulation. This technical correction corrects inaccurate citations to sections of the...
On January 17, 2017, the Office of Juvenile Justice and Delinquency Prevention (``OJJDP'') of the U.S. Department of Justice's Office of Justice Programs (``OJP''), published a partial final rule to amend portions of the formula grant program (``Formula Grant Program'') regulation to reflect changes in OJJDP policy. That rule is scheduled to...
Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments
On December 30, 2016, the Drug Enforcement Administration published a final rule to implement requirements associated with the International Trade Data System (ITDS) that will help streamline the export/import of tableting and encapsulating machines, controlled substances, and listed chemicals. That rule is scheduled to become effective January...
The Department of Justice is publishing its fall 2018 regulatory agenda pursuant to Executive Order 12866, ``Regulatory Planning and Review,'' 58 FR 51735, and the Regulatory Flexibility Act, 5 U.S.C. 601 to 612 (1988).
Aliens Subject to a Bar on Entry Under Certain Presidential Proclamations; Procedures for Protection Claims
The Department of Justice and the Department of Homeland Security (``DOJ,'' ``DHS,'' or, collectively, ``the Departments'') are adopting an interim final rule governing asylum claims in the context of aliens who are subject to, but contravene, a suspension or limitation on entry into the United States through the southern border with Mexico that...
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.